Placebo-controlled trial of venlafaxine for the treatment of major depression.

  title={Placebo-controlled trial of venlafaxine for the treatment of major depression.},
  author={Edward Schweizer and Charles Weise and Cathryn Clary and Ira Fox and Karl E. Rickels},
  journal={Journal of clinical psychopharmacology},
  volume={11 4},
Results are presented of the first double-blind, placebo-controlled trial of a novel antidepressant venlafaxine, which preclinically has demonstrated serotonin, norepinephrine, and dopamine reuptake inhibiting effects. Sixty outpatients meeting DSM-III-R criteria for major depression were randomized to receive 6 weeks of treatment with one of three fixed… CONTINUE READING
  • Blog articles referencing this paper

  • Presentations referencing similar topics